Neurocrine Biosciences (NBIX) Free Cash Flow (2010 - 2026)
Neurocrine Biosciences (NBIX) reported Free Cash Flow of $128.6 million for Q2 2026, up 43.7% from $89.5 million a year earlier but down 5.9% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Free Cash Flow (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Neurocrine Biosciences' Free Cash Flow came in at $870.4 million, up 64.6% year-over-year; for FY2025, it came in at $748.7 million, up 34.4% from FY2024.
- Free Cash Flow has increased for seven consecutive years, with a five-year compound annual growth rate of 28.0% (FY2020 to FY2025).
- By year, Free Cash Flow came in at $557.2 million in FY2024 (+54.1%), $361.6 million in FY2023 (+12.0%), $322.9 million in FY2022 (+38.5%) and $233.1 million in FY2021 (+7.1%).
- Five-year quarterly Free Cash Flow spans a low of -$133.7 million in Q1 2023 and a high of $390.8 million in Q4 2025.
- Year over year, Free Cash Flow has now increased in each of the last five quarters, with growth averaging 49.0% over the last eight quarters.
- The high point for year-over-year Free Cash Flow in five years was Q1 2026 (growth of 152.7%); the low point was Q2 2024 (a decline of 69.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $136.7 million (Q1 2026), $390.8 million (Q4 2025) and $214.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 7.30 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.11 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 4.48 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 6.20 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 5.34 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 3.49 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.43 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 302.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.01 Bn |
| 10 | Neurocrine Biosciences | 14.41 Bn | 10.11 Bn | 935.80 Mn | 128.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 128.60 Mn |
| Mar 31, 2026 | 136.70 Mn |
| Dec 31, 2025 | 390.80 Mn |
| Sep 30, 2025 | 214.30 Mn |
| Jun 30, 2025 | 89.50 Mn |
| Mar 31, 2025 | 54.10 Mn |
| Dec 31, 2024 | 235.20 Mn |
| Sep 30, 2024 | 149.90 Mn |
| Jun 30, 2024 | 53.00 Mn |
| Mar 31, 2024 | 119.10 Mn |
| Dec 31, 2023 | 118.10 Mn |
| Sep 30, 2023 | 204.40 Mn |
| Jun 30, 2023 | 172.80 Mn |
| Mar 31, 2023 | -133.70 Mn |
| Dec 31, 2022 | 141.20 Mn |
| Sep 30, 2022 | 100.50 Mn |
| Jun 30, 2022 | 129.30 Mn |
| Mar 31, 2022 | -48.10 Mn |
| Dec 31, 2021 | -4.70 Mn |
| Sep 30, 2021 | 56.10 Mn |
API Access
Neurocrine Biosciences Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();